Leerink Partners analyst Whit Mayo reiterated a Buy rating on AdaptHealth (AHCO – Research Report) on February 24. The company’s shares closed last Friday at $16.20, close to its 52-week low of $13.95.
According to TipRanks.com, Mayo is a 4-star analyst with an average return of 8.4% and a 56.8% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Privia Health Group, and Oak Street Health.
Currently, the analyst consensus on AdaptHealth is a Strong Buy with an average price target of $29.00, a 92.6% upside from current levels. In a report issued on February 24, Stifel Nicolaus also maintained a Buy rating on the stock with a $20.00 price target.
Based on AdaptHealth’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $653 million and net profit of $58.09 million. In comparison, last year the company earned revenue of $284 million and had a GAAP net loss of $51.04 million.
Based on the recent corporate insider activity of 48 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of AHCO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AdaptHealth Corp. provides medical products for both rental and sale. It focuses on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers, and hospital beds. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Read More on AHCO:
- Arcus Biosciences (RCUS) Gets a Buy Rating from Leerink Partners
- Robert W. Baird Sticks to Its Hold Rating for Everbridge (EVBG)
- Leerink Partners Keeps Their Buy Rating on ContraFect (CFRX)
- Robert W. Baird Sticks to Their Buy Rating for Axon Enterprise (AXON)
- Vericel (VCEL) Receives a Buy from Leerink Partners